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Objective To determine the cardiovascular and acid-base effects of 6% hydroxyethyl starch 12 
(HES) 130/0.4 and 0.9% sodium chloride (NaCl) administered to anaesthetized greyhounds 13 
with haemorrhagic shock. 14 
Study design Prospective, experimental, complete randomized block design. 15 
Animals Twelve healthy adult greyhounds. 16 
Methods After 60 minutes of isoflurane anaesthesia, 48 mL kg-1 of blood was removed to 17 
induce hypotension. Dogs were randomized to receive eith r 20 mL kg-1 of HES 130/0.4 or 18 
80 mL kg-1 of 0.9% NaCl over 20 minutes. Haemoglobin, arterial and central venous blood 19 
gas and electrolytes, lactate, mean arterial pressu (MAP), and cardiac index were measured 20 
at: T0, 60 minutes after induction of anaesthesia, immediately prior to blood removal; T1, 21 
immediately after blood removal; T2, immediately after fluid administration; and T3, 40 22 
minutes after fluid administration. Oxygen extraction ratio (O2ER) was calculated at each 23 
sample time. 24 
Results Oxygen extraction ratio increased at T1 and decreased t T2 and T3, with no 25 
difference between the two groups. Dogs administered HES 130/0.4 had higher lactate at T2 26 
[mean (95% confidence interval) 1.3 (0.8 - 1.9) mmol L-1] than dogs administered 0.9% NaCl  27 
[0.8 (0.5 - 1.1) mmol L-1]; p = 0.045. Dogs administered HES 130/0.4 had a higher MAP at 28 
T3 [88 (74-102) mmHg] than dogs administered 0.9% NaCl [69 (60-79) mmHg]; p = 0.019. 29 
Dogs administered 0.9% NaCl were more acidaemic at T2 and T3, including higher hydrogen 30 
ion, lower bicarbonate, lower base excess, and higher c loride concentrations.  31 
Conclusion and clinical relevance The effect of 20 mL kg-1 of HES 130/0.4 on shock, as 32 
measured by O2ER, was no different than 80 mL kg













anaesthesia. Acidaemia in the NaCl group is likely attributable to a hyperchloraemic 34 
metabolic acidosis from the larger volume administered.  35 
Keywords acid-base balance, fluid therapy, haemorrhage, Hydrox ethyl starch 130/0.4, shock 36 
 37 
Introduction 38 
Hypovolaemic shock secondary to haemorrhage is a known complication of surgery (Gaynor 39 
et al. 1999) and trauma (Bishop et al. 1993) that can result in organ dysfunction and death 40 
(Bishop et al. 1993; Mythen and Webb 1994). Rapid expansion of intravascular volume with 41 
fluid therapy is an important first step in minimizing organ dysfunction (Bishop et al. 1995).  42 
As haemorrhage reduces total protein and oncotic pressure, artificial colloid solutions that 43 
increase oncotic pressure can be administered for blo d volume expansion (Haupt and 44 
Rackow 1982; James et al. 2004; Silverstein et al. 2005; Aarnes et al. 2009; Lobo et al. 45 
2010). Artificial colloid solutions such as hydroxyethyl starch (HES) 130/0.4 have produced 46 
equal or greater increases in haemodynamic function ompared to similar doses of crystalloid 47 
solutions in people with shock (Ferreira et al. 2005; Gondos et al. 2010; Lobo et al. 2010).  48 
One study in splenectomized dogs with haemorrhagic sho k under general anaesthesia 49 
showed no difference in cardiovascular parameters  after administration of 28 mL kg-1 of 50 
HES 130/0.4 compared to 84 mL kg-1 of lactated Ringers solution (LRS) (Barros et al. 2011). 51 
As splenic contraction is an important compensatory mechanism in the resolution of shock in 52 
dogs (Hsia et al. 2007), this study does not accurately demonstrate the response to different 53 
fluid types in the clinical setting. In addition, this study used a ratio of the volume of colloid 54 
fluid to crystalloid fluid of 1:3, whereas the current recommendations of colloid fluid to 55 













found there was no difference in blood volume expansion with the administration of 20 mL 57 
kg-1 of HES 670/0.75 or 80 mL kg-1 of 0.9% sodium chloride (NaCl) in a euvolaemic canine 58 
model, 30 minutes after redistribution of fluids (Silverstein et al. 2005). Also, the study by 59 
Barros et al. used LRS as a comparison solution whereas HES 130/0.4 is most commonly 60 
suspended in 0.9% NaCl. Administration of large volumes of 0.9% NaCl may cause 61 
metabolic acidosis (Scheingraber, 1999). Therefore, a more appropriate crystalloid 62 
comparison in regards to assessing the cardiovascular and acid-base effects of HES 130/0.4 63 
would be 0.9% NaCl.  64 
The objective of this study was to determine the cardiovascular and acid-base effects of a 65 
clinically relevant dose of HES 130/0.4 administered to greyhounds with haemorrhagic shock 66 
under general anaesthesia. This study was designed to t st the hypothesis that cardiovascular, 67 
haemodilution and acid-base parameters will be different after administration of 20 mL kg-1 68 
of HES 130/0.4 compared to 80 mL kg-1 of 0.9% NaCl. The null hypothesis was that there is 69 
no difference between treatments.   70 
 71 
Materials and methods 72 
This study was part of a larger project (McBride et al. 2016) and was approved by the 73 
Murdoch University Animal Ethics Committee (2398/11). Twelve adult greyhound dogs 74 
deemed healthy based on physical examination and complete blood count were included. The 75 
dogs were not fasted and had free access to water. Each dog was assigned to receive either 76 
HES 130/0.4 (n = 6) or 0.9% NaCl (n = 6) based on selection of a se led envelope 77 
designating treatment. We estimated that a sample size of 6 would give us 80% power (alpha 78 
= 0.05) to detect an effect size of 0.6 between the two groups with all parameters, with the 79 













The dogs were premedicated with 0.2 mg kg-1 of methadone (Methone, Parnell Australia Pty 81 
Ltd, Australia) given intramuscularly. Thirty minutes after premedication, a 20-gauge 1-inch 82 
over-the-needle catheter was aseptically placed in the right cephalic vein, and anaesthesia 83 
was induced with 2.5 mg kg-1 of alfaxalone (Alfaxan, Jurox Pty Ltd, Australia) given 84 
intravenously. Animals were placed in left lateral recumbency, orotracheally intubated and 85 
anaesthesia was maintained with isoflurane (ISO Veterinary Companies of Australia, 86 
Australia) delivered in up to 98% oxygen via a circle breathing system. Vaporizer settings 87 
were adjusted to achieve an end-tidal isoflurane concentration of 1.4% measured using an 88 
agent monitor (Capnomac Ultima, Darex-Ohmeda Medical Supplies Australia, Australia). 89 
Mechanical ventilation was provided using a volume-controlled time-cycled ventilator 90 
(Model TH-1 Beijing Read Eagle Technology Co Ltd, China) at a rate of 10 breaths minute-1 91 
with an initial tidal volume of 20 mL kg-1. This was adjusted according to blood gas 92 
measurement at the end of the instrumentation period, to achieve an arterial carbon dioxide 93 
tension of PaCO2 35 - 40 mmHg (4.7 – 5.3 kPa) in all dogs. No furthe adjustment was made 94 
throughout the remainder of anaesthesia. Hartmann’s solution (Baxter Healthcare Pty Ltd 95 
Australia, Australia) was administered via the cephalic catheter at a rate of 10 mL kg hour-1 96 
until the time of administration of the treatment solutions. A 12-gauge 6-inch over-the-needle 97 
catheter was aseptically placed in the right jugular vein, with the distal end premeasured to be 98 
placed beyond the thoracic inlet, palpated as the cranial aspect of the first sternebra. A 14-99 
gauge 2-inch over-the-needle catheter was surgically placed in the left femoral artery. The 100 
catheters were connected via fluid filled transducers (DTX Plus Argon Critical Care Systems, 101 
Singapore) to a multivariable monitor (Surgivet V9203 Sound Medical, Australia) and 102 
calibrated to atmospheric pressure. Heart rate (HR), electrocardiogram, central venous 103 
pressure (CVP), and pulse oximetry were monitored with the multivariable monitor 104 













applying warm air to the right lateral surface of the dog (Bair Hugger warming unit Model 106 
505, Critical Assist, Australia). 107 
Sixty minutes after induction of anaesthesia, haemorrhagic shock was induced by removing 108 
48 mL kg-1 of blood over a 30 minute period from the femoral arterial catheter. Blood was 109 
collected into sterile blood collection bags and donated to the hospital’s blood bank for 110 
clinical use. The volume of blood removal was chosen based on preliminary data showing 111 
that removal of this amount of blood was required in order to reliably induce clinically 112 
relevant hypotension in greyhounds (Raisis et al. 2015). Following removal of 48 mL kg-1 of 113 
blood, intravenous Hartmann’s solution administration was discontinued and the dogs were 114 
administered either 20 mL kg-1 of HES 130/0.4 (Voluven 6% hydroxyethyl starch 130/0.4, 115 
Fresnius Kabi Deutschland GmbH, Germany) or 80 mL kg-1 of 0.9% NaCl intravenously 116 
over 20 minutes. These doses were chosen based on a previous study in a euvolaemic model 117 
(Silverstein et al. 2005). Hydroxyethyl starch 130/0.4 was delivered using a pressure bag via 118 
the cephalic catheter and 0.9% NaCl was delivered using two pressure bags via the cephalic 119 
and jugular catheters. The pressure applied to each b g was monitored throughout to ensure 120 
the fluid was delivered continuously during the 20 minute period.  121 
Data for analysis was collected at four time points (Fig. 1): T0, at baseline 60 minutes after 122 
induction, immediately prior to haemorrhage; T1, immediately after removing 48 mL kg-1 of 123 
blood over 30 minutes; T2, immediately after administration of 20 mL kg-1 of HES 130/0.4 or 124 
80 mL kg-1 of 0.9% NaCl over 20 minutes; and T3, 40 minutes after completion of respective 125 
fluid administration. At each time point, blood was collected simultaneously from the femoral 126 
arterial and jugular venous catheters into lithium heparin syringes. Arterial and venous blood 127 
gas analysis and arterial lactate, sodium, chloride, and haemoglobin (Hb) concentrations were 128 
measured using the radiometer (ABL 725 Radiometer Pacific Pty Ltd, Australia). Manual 129 













Immediately following blood collection, cardiac outp  (CO) was measured in duplicate 131 
using the lithium dilution (LiDCO Cardiac Sensor Systems, LiDCO Ltd, UK) technique 132 
(LiDCO) as previously described, (Shih et al. 2011) with modification of the dose of lithium 133 
chloride to 0.005 mmol kg-1 (Raisis et al. 2015) injected via the central venous catheter and 134 
withdrawing blood via the femoral artery. Sodium and Hb concentration were required for 135 
calculation of CO measurement. When two results varied greater than 10%, repeated 136 
measurements were made and the results varying greater th n 10% were excluded from 137 
analysis.  Simultaneously at the four time points, HR, direct MAP, and CVP were measured. 138 
The O2ER was calculated at each time point using the formulae in Table 1, which also 139 
includes all calculations required to calculate O2ER. 140 
At the conclusion of data collection, euthanasia was performed using intravenous 141 
pentobarbital.  142 
Statistical method 143 
All responses were tested for normality and found to follow a normal distribution with failure 144 
to reject the null hypothesis of normality at p < 0.05 using the Sharpiro-Wilk statistic. 145 
Response data was summarized and reported as mean (95% confidence intervals).  146 
Descriptive data of each group cohort are reported as mean ± standard deviation (SD). All 147 
responses were tested for a fixed effect of treatmen  (HES 130/0.4, 0.9% NaCl) and time (T0 148 
- T3) using a mixed linear model that included the random variance of dog nested within 149 
group.  Where there was a significant effect of group, post-hoc comparisons were made 150 
between groups at each time point using Scheffe’s adjustment with adjusted p values 151 
reported, considered significant at p < 0.05. Age, body weight and body surface area were 152 
compared across groups using a t-test with p < 0.05 considered significant. SAS v 9.4 (SAS 153 














Each group had three male and three female dogs. The body weight was 28.3 ± 3.9 kg for the 156 
HES 130/0.4 group and 28.3 ± 2.6 kg for the 0.9% NaCl group.  The age was 3 ± 2 and 4 ± 2 157 
years, respectively. There was no significant difference in body weight or age of the dogs 158 
across the two groups. 159 
Haemorrhage resulted in an increase in O2ER consistent with shock in both groups (Table 2). 160 
Both fluids reduced O2ER to baseline levels, with no significant differenc s between the two 161 
groups at any time point. Dogs administered HES 130/0.4 had a higher VO2 (p = 0.01) and 162 
Hb concentration (p < 0.001) at T2, and a higher MAP (p = 0.019) at T3 than dogs 163 
administered 0.9% NaCl. There was no significant difference between the two groups for any 164 
other cardiovascular or oxygen transport variables. 165 
At T0, dogs administered 0.9% NaCl had a higher hydrogen ion concentration (p = 0.021) 166 
compared to dogs administered HES 130/0.4 (Table 3). At T2 and T3, dogs administered 167 
0.9% NaCl had a higher hydrogen ion concentration (p = 0.03, p = 0.017, respectively), lower 168 
bicarbonate concentration (p = 0.002, p < 0.001, respectively), lower base excess 169 
concentration (p = 0.001, p < 0.0001, respectively), and higher chloride concentration (p < 170 
0.001, p = 0.001, respectively) compared to dogs administered HES 130/0.4. Dogs 171 
administered HES 130/0.4 had a marginally higher lactate concentration at T2 (p = 0.045).  172 
There was no significant difference between the two groups at other time points and with 173 
other values. 174 
Discussion 175 
This study demonstrated that 20 mL kg-1 of HES 130/0.4 and 80 mL kg-1 of 0.9% NaCl 176 













under anaesthesia, with no difference between the two groups. While 80 mL kg-1 of 0.9% 178 
NaCl administration resulted in a hyperchloraemic metabolic acidosis persisting for 40 179 
minutes (T3), 20 mL kg-1 of HES 130/0.4 administration did not. Some differences were also 180 
found immediately after fluid administration (T2). Dogs administered 0.9% NaCl had lower 181 
Hb concentration and VO2, likely the result of the greater amount of fluid a ministered and 182 
hence greater blood volume expansion at this time point. This change in Hb concentration 183 
was not present by T3, which can be explained by greate  fluid redistribution during this time 184 
period, compared to dogs administered HES 130/0.4. 185 
Oxygen extraction ratio is an objective measure of tissue oxygen utilization, and is an earlier 186 
marker of shock compared to other variables such as lactate (Ronco et al. 1993).  Oxygen 187 
extraction ratio is the amount of oxygen consumed by cells (VO2) in proportion to oxygen 188 
delivered (DO2). As DO2 is usually surplus to need, VO2 and O2ER are usually maintained 189 
within normal limits despite mild decreases in DO2. When DO2 is decreased to a level that 190 
VO2 becomes dependent on the amount of oxygen delivered, a decrease in VO2 and a rapid 191 
increase in O2ER is usually observed (Haskins et al. 2005). An interesting observation in our 192 
study was an increase in VO2 during shock rather than a decrease in VO2. This also has been 193 
observed in other studies in anaesthetized dogs (Yoo et al. 2007; Barros et al. 2011). One 194 
possible explanation for this is reduced ability for vasoconstriction during haemorrhagic 195 
shock while anaesthetized with isoflurane, a known vasodilatory agent (Schwinn et al. 1990). 196 
This can result in increased availability of capillary beds for oxygen exchange and increased 197 
VO2. Another explanation could be recruitment of capill ry beds and increased cellular 198 
metabolism in muscle resulting from increased catecholamine levels (Schlichtig et al. 1991). 199 
Interestingly, VO2 was significantly higher after HES 130/0.4 administration at T2. This is 200 
likely the result of less blood volume expansion at this time point, and it may be that an 201 













Although there was no difference in O2ER across dogs in each group, other variables 203 
including Hb and lactate concentrations were signifcantly different at T2. Haemoglobin 204 
concentration was significantly higher at T2 in dogs administered HES 130/0.4 indicating 205 
less blood volume expansion (Dill & Costill 1974), most likely the result of the difference in 206 
administered volumes. Forty minutes after fluid administration however, there was no 207 
difference in Hb concentration across between groups, which has also been observed with 208 
other HES solutions (Lamke & Liljedahl 1976; Silverstein et al. 2005). Another explanation 209 
for differences in haemoglobin between groups is indiv dual variability in splenic contraction 210 
during hypovolaemia (Hsia et al. 2007).  Lactate concentration was also significantly higher 211 
at T2 in dogs administered HES 130/0.4 but given th difference was marginal, it is 212 
considered clinically irrelevant. Small differences in lactate concentration may be  213 
attributable to differences in haemodilution, or lactate metabolism and clearance (Tashkin et 214 
al. 1972).   215 
The other major difference across dogs was the acid-base balance. Dogs administered 0.9% 216 
NaCl developed a hyperchloraemic metabolic acidosis, which persisted 40 minutes after fluid 217 
administration. The degree of the hyperchloraemic metabolic acidosis in these dogs is likely 218 
attributable to the larger volume administered. Curiously, this effect persisted at T3 in the 219 
dogs administered 0.9% NaCl despite there being no difference in haemodilution between the 220 
two groups at this time point. Although metabolic acidosis can have a negative impact on 221 
vasomotor tone (Capellini et al. 2013) and myocardial function (Mayoux et al. 1994), this 222 
was not reflected in a significant difference in systemic vascular resistance index SVRI or CI 223 
at T3. However, subtle differences in these variables may be one reason why dogs that 224 
administered 0.9% NaCl had a lower MAP at T3 when the effects where combined.  225 
Although the results suggest that the effect of 20 mL kg-1 of HES 130/0.4 was no different to 226 













potential adverse effects should be considered. Hydrox ethyl starch 130/0.4 has been 228 
associated with acute kidney injury in people with severe sepsis and septic shock (Brunkhorst 229 
& Oppert  2008; Guidet et al. 2012; Myburgh et al. 2012b; Perner et al. 2012) and increased 230 
bleeding and transfusion requirements (Franz et al. 2001; Deusch et al. 2003; Myburgh et al. 231 
2012a). Although experimental studies showed that HES 130/0.4 did not cause significant 232 
platelet dysfunction in vitro (Wurlod et al. 2015; McBride et al. 2013) or in vivo in dogs 233 
(McBride et al. 2016) large scale prospective clinial trials are required to determine if an 234 
increased risk of bleeding and acute kidney injury exists in dogs treated in the clinical setting. 235 
One of the limitations of this study is the greyhound model. Greyhounds are known to have 236 
different haemodynamic variables compared to non-greyhound breeds, including higher 237 
resting MAP, CO, SVRI (Cox et al. 1976), and blood v lume (Cortice 1943) compared to 238 
other dogs. Although the difference in haemodynamic and splenic response to acute 239 
haemorrhage between greyhound and other breeds has not been previously compared, there 240 
may be some differences. Greyhounds also have higher haematocrit values (Zaldivar-Lopez 241 
et al. 2011b), which will affect blood viscosity and haemodynamics (Levy & Share 1953).  In 242 
addition, differences in haematocrit will also directly affect O2ER. Blood gas and co-243 
oximetry values are also different in greyhounds including higher pH, arterial oxygen content 244 
of blood, and arterial oxygen saturation, which will also influence O2ER (Zaldivar-Lopez et 245 
al. 2011a). Therefore, absolute values in this study cannot be directly extrapolated to other 246 
dog breeds.  247 
This study only had a sample size of six in an unpaired design, and type II error may be 248 
responsible for conclusions of no difference.  Perhaps of most interest would be the lack of 249 
difference in O2ER, where sample sizes of 193 and 770 dogs would be required to detect the 250 
differences recorded between treatments at T2 and T3, respectively. Although there was 251 













what was used to estimate sample size. Differences reflecting this smaller effect size are 253 
unlikely to be of clinical relevance. Therefore, if a small difference does exist, it is likely not 254 
worth pursuing with a larger sample size based on the results of this study.   255 
In conclusion, administration of 20 mL kg-1 of HES 130/0.4 and 80 mL kg-1 of 0.9% NaCl 256 
resulted in decreases in O2ER to within normal canine reference intervals with no difference 257 
between dogs receiving either treatment. This information may help to guide fluid bolus 258 
volume choice, depending on fluid type, in clinical p tients. Although there may have been 259 
greater blood volume expansion immediately after administration of 80 mL kg-1 of 0.9% 260 
NaCl, HES 130/0.4 resulted in a slightly higher MAP 40 minutes after administration. 261 
Administration of HES 130/0.4 also resulted in less acidaemia. Future clinical research is 262 
needed to characterise the clinical relevance of any adverse effects of both high-chloride 263 
fluids and HES fluid preparations.  264 
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Figure Legends 375 
Figure 1 Time-line of study protocol for fluid administration and data collection from 12 376 
anaesthetised greyhounds at four time points: T0, 60 minutes after induction of anaesthesia, 377 
immediately prior to blood removal; T1,during haemorrhagic shock, after removing 48 mL 378 
kg-1 of blood; T2, immediately after fluid administration of 20 mL kg-1 of hydroxyethyl 379 
starch (HES)130/0.4 or 80 mL kg-1 of 0.9% sodium chloride (NaCl) over 20 minutes; and T3, 380 
40 minutes after completion of respective fluid administration. 381 
 382 













Table 1 Formulas required to calculate oxygen extraction ratio (Haskins et al. 2005). 384 
 385 
Calculated variable (units)  Abbreviation  Formula 
Arterial oxygen content (mL dL-1) CaO2 (1.34 x Hb x SaO2) + (0.003 x PaO2)  
Venous oxygen content (mL dL-1) CvO2 (1.34 x Hb x SvO2) + (0.003 x PvO2)  
Cardiac index (L minute-1 m2-1) CI CO/BSA 
Systemic vascular resistance index (dynes.sec.cm-5 
m2-1) 
SVRI ((MAP – CVP)79.92)/CI 
Oxygen delivery index (mL minute-1 m2-1) DO2 CaO2 x CI x 10  
Oxygen consumption index (mL minute-1 m2-1)  VO2 (CaO2 – CvO2) x CI x 10 
Oxygen extraction ratio (%) O2ER VO2/DO2 x 100 
Body surface area (m2) BSA (10.1 x body weight 0.67) x 10-4  
 386 
Haemoglobin concentration (Hb), arterial oxyhaemoglobin saturation (SaO2), partial pressure 387 
of oxygen in arterial blood (PaO2), venous oxyhaemoglobin saturation (SvO2), partial 388 
pressure of oxygen in venous blood (PvO2), cardiac output (CO), mean arterial pressure 389 













Table 2 Mean and 95% confidence interval of cardiovascular and oxygen (O2) transport variables in 12 anaesthetised greyhounds at four time 391 
points: T0, baseline; T1, during haemorrhagic shock, after removing 48 mL kg-1 of blood; T2, immediately after administration of 20 mL kg-1 of 392 
hydroxyethyl starch (HES) 130/0.4 or 80 mL kg-1 of 0.9% sodium chloride (NaCl) over 20 minutes; and T3, 40 minutes after completion of 393 
respective fluid administration.    394 
  Timepoints 
Parameter Group T0 T1 T2 T3 
Haemoglobin (g L-1)  0.9% NaCl  17.5 (16.1–18.8) 16.8 (15.7–17.9) 8.6 (7 8–9.5) 11.1 (9.9–12.2) 
 HES 130/0.4 18.3 (17.0–19.6) 16.8 (15.9–17.6) 11.5 ( 0.8–12.2)* 10.5 (9.7–11.4) 
Heart rate (beats minute-1) 0.9% NaCl  82 (63-102) 151 (124-179) 117 (105-129) 119 (103-135) 
 HES 130/0.4 75 (69-82) 157 (134-181) 124 (105-143) 122 (99-145) 
Mean arterial pressure 
(mmHg) 
0.9% NaCl 80 (69-91) 36 (26-47) 71 (57-85) 69 (60-79) 
 HES 130/0.4 
 
81 (70-91) 36 (23-48) 86 (72-100) 88 (74-102)* 














 HES 130/0.4 
 
4.0 (3.3-4.7) -1.3 (-3.2-0.5) 2.7 (0.4-4.9) 2.8 (1.6-4 1) 




3.7 (2.7-4.6) 1.8 (1.3-2.3) 4.3 (3.4-5.1) 4.1 (3.6-4 ) 
 HES 130/0.4 
 
3.7 (2.9-4.5) 1.5 (1.0-2.0) 5.1 (3.1-7.0) 5.3 (3.2-7 5) 
Systemic vascular resistance 
index (dynes.sec.cm-5 m2-1) 
0.9% NaCl 1708 (1229-2187) 1690 (1262-2118) 1235 (994-1476) 1305 (1054-1557) 
 HES 130/0.4 
 
1691 (1452-1930) 1995 (1567-2423) 1411 (1025-1798) 1350 (1036-1664) 





931 (651-1212) 435 (288-582) 567 (462-673) 680 (553-807) 
 HES 130/0.4 
 
968 (780-1155) 369 (234-502) 877 (498-1257) 861 (440-1281) 













(mL minute-1 m2-1) 303.0) 
 HES 130/0.4 
 





O2 extraction ratio (%) 0.9% NaCl 
 
9 (6-13) 51 (31-71) 9 (6-12) 10 (5-15) 
 HES 130/0.4 
 
8 (5-9) 68 (61-75) 13 (7-20) 9 (4-14) 
Central venous O2 saturation 
(mmHg) 
0.9% NaCl 96 (93-100) 52 (31-73) 100 (99-100) 98 (94-101) 
 HES 130/0.4 
 
98 (95-100) 34 (26-42) 94 (87-101) 98 (95-101) 
Arteriovenous CO2 
difference (mmHg) 
0.9% NaCl 4.9 (2.9-6.9) 10.3 (4.2-16.4) 4.3 (0.0-8.5) 6.9 (5.3-8.5) 
 HES 130/0.4 
 
4.4 (2.4-6.4) 12.1 (7.7-16.5) 8.0 (5.0-11.0) 5.3 (3.4-7.3) 













Table 3 Mean and 95% confidence interval of acid-base variables in 12 anaesthetized greyhounds at four time points: T0, baseline; T1, during 
haemorrhagic shock, after removing 48 mL kg-1 of blood; T2, immediately after administration of 20 mL kg-1 of hydroxyethyl starch (HES) 
130/0.4 or 80 mL kg-1 of 0.9% sodium chloride (NaCl) over 20 minutes; and T3, 40 minutes after completion of respective fluid administration.    
 
 
  Timepoints    
Parameter Group T0 T1 T2 T3 
Blood pH 0.9% NaCl 
 
7.39 (7.34-7.43) 7.36 (7.29-7.434) 7.24 (7.20-7.28) 7.33 (7.28-7.38) 
 HES 130/0.4 
 
7.44 (7.42-7.46) 7.44 (7.40-7.48) 7.33 (7.25-7.41) 7.40 (7.37-7.43) 
Hydrogen (nmol L-1) 0.9% NaCl 
 
4.1 (3.7-4.5) 4.4 (3.7-5.1) 5.8 (5.2-6.3) 4.7 (4.1-5 3) 
 HES 130/0.4 
 
3.6 (3.4-3.8)* 3.6 (3.3-3.9) 4.7 (3.8-5.6)* 4.0 (3.7-4.3)* 


















0.9% NaCl 24 (21-28) 22 (19-24) 18 (16-20) 20 (18-22) 
 HES 130/0.4 26 (24-27) 23 (21-25) 22 (21-24)* 26 (4-28)* 
 
Base excess (mEq L-
1) 
0.9% NaCl -0.1 (-3.4-3.3) -2.9 (-6.2-0.4) -8.2 (-10.6- -5.9) -5.4 (-7.9- -2.8) 
 HES 130/0.4 
 
2.6 (0.6-4.6) 0.0 (-1.8-1.8) -3.1 (-4.9- -1.2)* 1.3 (-0.7-3.3)* 
Chloride (mmol L-1) 0.9% NaCl 
 
116 (114-118) 118 (117-119) 128 (126-130) 125 (124-6) 
 HES 130/0.4 
 
117 (115-119) 118 (117-120) 122 (120-125)* 120 (117- 23)* 














 HES 130/0.4 
 
0.9 (0.6-1.2) 1.6 (1.3-1.9) 1.3 (0.8-1.9)* 0.8 (0.6- .9) 
 
 
Comparisons were made for each parameter between groups at each time point. *Scheffe adjusted p value < 0.05. Statistical analysis was not 


























80 mL kg¯¹ 
0.9% NaCl 
(n = 6)
20 mL kg¯¹ 

























D1 Do you think the times written below is confusing? I put brackets in the 1st two to see if it helps the reader...? What do you think?
I feel "Fluid redistribution" may not be the right term. 
And the distance between the vertical lines doesn't match the time frame. Do you think we should change the distance between the vertical 
lines to make it proportional to the time intervals?
Duana, 27-03-2015
